Barclays’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.22M Buy
839,894
+474,859
+130% +$1.25M ﹤0.01% 2161
2025
Q1
$1.1M Sell
365,035
-31,449
-8% -$94.7K ﹤0.01% 2392
2024
Q4
$1.02M Buy
396,484
+35,448
+10% +$90.7K ﹤0.01% 2629
2024
Q3
$1.34M Buy
361,036
+202,248
+127% +$753K ﹤0.01% 2437
2024
Q2
$1M Sell
158,788
-226,881
-59% -$1.43M ﹤0.01% 2116
2024
Q1
$2.07M Sell
385,669
-93,876
-20% -$504K ﹤0.01% 1918
2023
Q4
$2.41M Buy
479,545
+435,172
+981% +$2.18M ﹤0.01% 2036
2023
Q3
$75K Sell
44,373
-16,096
-27% -$27.2K ﹤0.01% 3429
2023
Q2
$168K Buy
60,469
+19,181
+46% +$53.3K ﹤0.01% 3172
2023
Q1
$75K Sell
41,288
-215,077
-84% -$391K ﹤0.01% 3661
2022
Q4
$1.3M Buy
256,365
+3,335
+1% +$16.9K ﹤0.01% 1929
2022
Q3
$1.26M Buy
253,030
+242,167
+2,229% +$1.2M ﹤0.01% 1958
2022
Q2
$40K Sell
10,863
-778
-7% -$2.87K ﹤0.01% 3814
2022
Q1
$66K Buy
+11,641
New +$66K ﹤0.01% 3870
2021
Q1
Sell
-37,686
Closed -$503K 3924
2020
Q4
$503K Sell
37,686
-18,316
-33% -$244K ﹤0.01% 2316
2020
Q3
$388K Buy
56,002
+1,446
+3% +$10K ﹤0.01% 2431
2020
Q2
$670K Buy
54,556
+54,516
+136,290% +$670K ﹤0.01% 2159
2020
Q1
$0 Sell
40
-42
-51% ﹤0.01% 3768
2019
Q4
$0 Hold
82
﹤0.01% 4022
2019
Q3
$0 Sell
82
-2,062
-96% ﹤0.01% 4245
2019
Q2
$3K Sell
2,144
-6,629
-76% -$9.28K ﹤0.01% 4114
2019
Q1
$14K Buy
8,773
+7,814
+815% +$12.5K ﹤0.01% 3965
2018
Q4
$1K Sell
959
-10,481
-92% -$10.9K ﹤0.01% 4000
2018
Q3
$42K Buy
11,440
+9,332
+443% +$34.3K ﹤0.01% 3782
2018
Q2
$6K Sell
2,108
-11,439
-84% -$32.6K ﹤0.01% 3984
2018
Q1
$52K Sell
13,547
-14,539
-52% -$55.8K ﹤0.01% 3488
2017
Q4
$126K Buy
28,086
+1,584
+6% +$7.11K ﹤0.01% 2888
2017
Q3
$145K Buy
26,502
+1,112
+4% +$6.08K ﹤0.01% 2541
2017
Q2
$193K Sell
25,390
-60,967
-71% -$463K ﹤0.01% 2452
2017
Q1
$306K Buy
86,357
+83,192
+2,628% +$295K ﹤0.01% 2250
2016
Q4
$18K Sell
3,165
-594
-16% -$3.38K ﹤0.01% 3117
2016
Q3
$30K Buy
3,759
+2,397
+176% +$19.1K ﹤0.01% 2908
2016
Q2
$8K Buy
1,362
+801
+143% +$4.71K ﹤0.01% 3040
2016
Q1
$4K Sell
561
-973
-63% -$6.94K ﹤0.01% 3094
2015
Q4
$26K Buy
+1,534
New +$26K ﹤0.01% 2650